Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction by Perrino, C.
Research article
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 116      Number 6      June 2006  1547
Intermittent pressure overload triggers 
hypertrophy-independent cardiac dysfunction 
and vascular rarefaction
Cinzia Perrino,1 Sathyamangla V. Naga Prasad,1 Lan Mao,1 Takahisa Noma,1 Zhen Yan,1  
Hyung-Suk Kim,2 Oliver Smithies,2 and Howard A. Rockman1




























































The duration of stress on the heart determines the magnitude of LV hyper-
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Duration of stress determines the magnitude of LV hypertrophy development. (A) Experimental design of the 4-week study involving different 
models of physiological hypertrophy (swimming or running) or pressure overload (chronic or intermittent). Sedentary and sham-operated mice 
were used as controls for swimming/running and iTAC/cTAC groups, respectively, and are shown as a single control group (Con). (B) Repre-
sentative tracings showing the invasive measurement of arterial pressures in the right carotid and left axillary arteries in iTAC and cTAC mice. 
In all iTAC animals included in the study, pulling of the externalized suture caused a rapid increase in the right carotid systolic pressure, with 
or without a decrease in the left axillary systolic pressure that promptly regressed after release of the suture. (C) LV/BW ratios in mice from the 
different groups. Filled circles with error bars indicate average ± SEM. *P < 0.05 versus control; ##P < 0.01 versus all other groups; ANOVA with 
Neuman-Keuls correction. (D) LV/BW ratios plotted against systolic pressure gradients measured at study termination in iTAC and cTAC mice. 
(E) Representative echocardiograms from the different groups of animals after 4 weeks of different protocols. (F) Percent FS in mice from the 
different groups. ##P < 0.01 versus all other groups; ANOVA with Bonferroni correction. (G) Percent FS plotted against systolic pressure gradients 
(SPG) measured at study termination in iTAC and cTAC mice.
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P h y s i o l o g i c a l l y - a p p l i e d 
pressure overload induces a 
physiological gene expression 





the  reexpression  of  fetal 







per  group).  Overall,  iTAC 
mice revealed a gene expres-
sion profile that was more 







Echocardiographic and morphometric evaluation of hypertrophic mouse hearts after 4 weeks (experimen-
tal design I)
	 	 Control	 Swimming	 Running	 iTAC	 cTAC
Echocardiography n = 15 n = 16 n = 19 n = 24 n = 29
 LVEDD (mm) 2.7 ± 0.1 2.9 ± 0.1A 2.9 ± 0.1A 2.7 ± 0.1 2.9 ± 0.1A
 LVESD (mm) 1.0 ± 0.1 1.2 ± 0.1  1.1 ± 0.1 1.1 ± 0.1 1.7 ± 0.1B
 IVS (mm) 0.7 ± 0.1 0.7 ± 0.1 0.8 ± 0.1 0.9 ± 0.1A 1.1 ± 0.1A
 PW (mm) 0.6 ± 0.1 0.6 ± 0.1 0.8 ± 0.1 0.9 ± 0.1A 1.1 ± 0.1A
 FS (%) 61.5 ± 1.5 59.9 ± 1.5 61.8 ± 1.1 60.6 ± 1.4 43.4 ± 1.8B
 Vcfc (circ/s) 4.4 ± 0.1 4.3 ± 0.2 4.8 ± 0.2  4.1 ± 0.2 3.2 ± 0.1B
 HR (bpm) 643 ± 10 566 ± 13B 622 ± 9 646 ± 8 636 ± 7
Organ morphometry n = 22 n = 21 n = 25 n = 17 n = 23
 BW (g) 21.0 ± 0.3 19.2 ± 0.3 21.3 ± 0.2 21.0 ± 0.6 20.7 ± 0.3
 LA (mg) 2.8 ± 0.1 3.6 ± 0.1 3.2 ± 0.1 5.2 ± 0.4A 8.7 ± 1.2B
 LV/BW (mg/g) 3.3 ± 0.03 3.9 ± 0.06A 3.8 ± 0.05A 3.7 ± 0. 07A 6.0 ± 0.25B
 H/BW (mg/g) 4.6 ± 0.03 5.2 ± 0.05A 5.1 ± 0.05A 4.9 ± 0.10A 7.4 ± 0.31B
 L/BW (mg/g) 7.5 ± 0.1 7.4 ± 0.3 7.0 ± 0.1 8.4 ± 0.5A 10.5 ± 0.8B
Cellular morphometry n = 6 n = 6  n = 4 n = 8
 CM width (mm) 21.1 ± 0.5 23.4 ± 0.9 – 25.0 ± 0.5A 25.1 ± 0.9A
 CM area (mm2) 2,286.7 ± 61.5 2,609.0 ± 68.5A – 2,599.7 ± 68.8A 2,801.9 ± 88.1A
LVEDD, LV end-diastolic diameter; LVESD, LV end-systolic diameter; IVS, interventricular septum; PW, posterior wall; 
Vcfc, ventricular circumferential shortening, corrected by heart rate; circ/s, circumferential shortening per second; HR, 
heart rate; LA, left atrium weight; H/BW, heart weight/BW; L/BW, lung weight/BW; CM, cardiomyocyte. AP < 0.01 versus 
control. BP < 0.001 versus all other groups. Comparisons were made using ANOVA with Neuman-Keuls correction for 
echocardiography and organ morphometry and Student’s t test with Bonferroni correction for cellular morphometry.
Figure 2
Chronic pathological stress is required to induce the fetal gene expres-
sion reprogramming. (A) Gene expression analysis of renal renin in 
kidneys of swimming, running, iTAC, and cTAC mice by RT-PCR. Data 
are shown as fold change over control ± SEM. Differences were not 
significant. (B and C) Gene expression analysis of α and b isoforms of 
MHC, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), 
angiotensin II type 1a receptor (ATR), adrenomedullin (AM) and natri-
uretic peptide receptor A (NPRA) in hearts of swimming, iTAC, and 
cTAC mice by real-time RT-PCR of LV mRNA. Sedentary animals were 
used as controls for swimming mice; sham-operated animals were used 
for iTAC or iTAC. Data are shown as fold change over control ± SEM. 
#P < 0.05 versus swimming; ‡P < 0.01 versus iTAC; Student’s t test.
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Hearts exposed to physiologically applied pressure overload dis-
play a pathological structural and cellular phenotype. (A) Represen-
tative staining of cardiac sections with H&E (magnification, ×400), 
MT (magnification, ×20), and endothelial alkaline phosphatase (to 
determine capillary density, CD; magnification, ×400). (B) Quantifi-
cation of capillary density in cardiac sections stained for endothelial 
alkaline phosphatase expressed as percent change from control. 
**P < 0.01 versus control; ANOVA with Bonferroni correction. (C) 
Summary data for contractility studies of cardiac cells isolated from 
hearts of control, swimming, iTAC, and cTAC mice after 4 weeks 
of training (n = 5–10 mice per group; in each heart, 10–15 cells 
were analyzed under basal conditions and following ISO stimula-
tion). Percent CS under basal conditions (white bars) and following 
ISO stimulation (black bars) is shown. ‡P < 0.01 versus respective 
basal group; **P < 0.01 versus corresponding control and swim-
ming groups; ANOVA with Neuman-Keuls correction.
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bAR dysfunction is an early molecular sensor of pathological pressure overload. (A) bAR density among membranes from hearts of control 
(n = 17), swimming (n = 7), running (n = 9), iTAC (n = 7), and cTAC (n = 11) mice. **P < 0.01 versus control. (B) Adenylyl cyclase activity at basal 
levels (white bars) and upon ISO stimulation (black bars) in hearts of control (n = 15), swimming (n = 9), running (n = 7), iTAC (n = 6), and cTAC 
(n = 9) mice. ‡P < 0.01 versus respective basal group; **P < 0.01 versus control ISO; ANOVA with Bonferroni correction. (C) Myocardial lysates 
(80 mg) of hearts from control, swimming, running, iTAC, and cTAC mice, along with the purified protein (+), were immunoblotted for bARK1. 
(D) Representative PI3K assay showing bARK1-associated PI3K activity in membrane lysates from hearts of control, swimming, running, iTAC, 
and cTAC mice (left panel). Summary data for all the experiments performed (n = 4–7 hearts per group) are shown at right. (E and F) Summary 
data for PI3Kg (E) and PI3Ka activity (F) in cytosolic lysates from the same hearts. Ori, origin; PIP, phosphatidylinositol monophosphate; PIP2, 
phosphatidylinositol bisphosphate. **P < 0.01 versus control; Student’s t test with Bonferroni correction.
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Transgenic inhibition of bAR-targeted PI3K activity preserves bAR sig-




































Transgenic inhibition of bAR-targeted PI3K activity preserves bAR signaling upon intermittent pressure overload. (A) Experimental design of the 
1-week study involving WT and PI3Kginact transgenic mice. (B) LV/BW ratios in mice from the different groups. ##P < 0.01 versus all other groups; 
ANOVA with Bonferroni correction. Filled circles with error bars indicate average ± SEM. (C) LV/BW ratios plotted against respective systolic 
pressure gradients measured at study termination in iTAC, iTACginact, and cTAC mice. (D and E) Plasma levels of catecholamines norepinephrine 
(D) and epinephrine (E) in the different groups. **P < 0.01 versus control. (F) bAR density among membranes from hearts of control (n = 12), 
iTAC (n = 10), iTACginact (n = 9), and cTAC (n = 11) mice. ‡P < 0.01 versus control and iTACginact; ANOVA with Bonferroni correction.
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Overexpression of PI3Kginact rescues early functional abnormalities in 
iTAC hearts. To determine the functional consequences of the early 
bAR defects and their normaliza-
tion  through  overexpression  of 
PI3Kginact, we measured hemody-
namic indices of myocardial sys-



































Beta blocker treatment preserves bAR levels and coupling in response to 





















Echocardiographic and hemodynamic parameters in mice after 1 week of treatment (experimental 
design II)
	 Control		 Swimming		 iTAC	 iTACginact	 cTAC
 (n = 11) (n = 9) (n = 9) (n = 9) (n = 15)
Echocardiography
 HR (bpm) 676 ± 9  – 630 ± 9A 674 ± 9 657 ± 7
 LVEDD (mm) 2.6 ± 0.05 – 2.6 ± 0.06 2.6 ± 0.04  2.8 ± 0.08A
 IVS (mm) 0.7 ± 0.02 – 0.9 ± 0.04A 0.9 ± 0.02A 1.0 ± 0.08A
 PW (mm) 0.6 ± 0.01 – 0.8 ± 0.03A 0.8 ± 0.03A 0.9 ± 0.06A
 FS (%) 63.9 ± 1.3 – 64.9 ± 1.6 67.0 ± 1.1 52.2 ± 2.5A
Pressure-volume loop analysis
 HR (bpm) 316 ± 17 298 ± 8 292 ± 14 321 ± 28 287 ± 11
 ESV (ml) 15.4 ± 2.2 16.7 ± 1.6 21.5 ± 3.0 12.9 ± 1.0 19.4 ± 2.1
 EDV (ml) 36.8 ± 2.2 37.8 ± 1.9 39.8 ± 3.1 37.9 ± 3.2 38.2 ± 2.6
 Ea (mmHg/ml) 3.9 ± 0.3 3.6 ± 0.4 4.3 ± 0.8 3.2 ± 0.2 3.6 ± 0.3
Systolic function
 Max. press. (mmHg) 96.7 ± 3.2 89.9 ± 5.5 81.3 ± 5.0 98.1 ± 6.4 89.7 ± 3.2
 ESP (mmHg) 89.8 ± 3.9 83.5 ± 6.0 75.0 ± 4.8 87.9 ± 5.9 76.2 ± 3.4
	 dP/dtmax (mmHg/s) 7,011 ± 333 5,979 ± 309 4,025 ± 234A 4,532 ± 215A 5,275 ± 280A
 EF (%) 65.0 ± 3.3 60.2 ± 1.7 50.8 ± 5.8 67.8 ± 1.9B 56.6 ± 3.8
 SV (ml) 24.2 ± 1.6 23.7 ± 0.8 21.2 ± 3.1 28.2 ± 2.3 23.6 ± 1.9
 CO (ml/min) 7.6 ± 0.6 7.1 ± 0.3 6.1 ± 0.9 8.3 ± 0.7B 6.5 ± 0.6
 Ees (mmHg/ml) 4.1 ± 0.4 3.8 ± 0.4 6.5 ± 0.8A 5.3 ± 0.5 8.0 ± 0.9A
Diastolic function
 EDP (mmHg) 8.2 ± 1.3 7.8 ± 0.7 18.7 ± 3.0A 12.8 ± 2.3 13.9 ± 1.2A
	 dP/dtmin (mmHg/s) –5,571 ± 201 –4,750 ± 282 –3,259 ± 426A –3,324 ± 271A –3,292 ± 260A
 t Glantz (ms) 22.6 ± 0.7 25.2 ± 1.2 33.0 ± 2.8A 21.7 ± 1.7B 38.5 ± 3.8A
 EDPVR (mmHg/ml) 0.5 ± 0.1 0.5 ± 0.1 1.4 ± 0.3A 0.4 ± 0.1B 0.9 ± 0.1A
ESV, end-systolic volume; EDV, end-diastolic volume; Ea, elastic elastance; Max. press., maximum pressure; 
ESP, end-systolic pressure; EF, ejection fraction; SV, stroke volume; CO, cardiac output; EDP, end-diastolic 
pressure. AP < 0.05 versus control. BP < 0.05 versus iTAC. Comparisons were made using Student’s t test with 
Bonferroni correction for multiple comparisons.
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Preservation of bAR signaling through targeted PI3K inhibition is associated with preservation of capillary density and SERCA2a levels. (A) 
Representative staining of cardiac sections with H&E (magnification, ×400), MT (magnification, ×20), and endothelial alkaline phosphatase (to 
determine capillary density; magnification, ×400) after 1 week of training. (B) Quantification of capillary density in cardiac sections stained for 
endothelial alkaline phosphatase expressed as percent reduction from control (n = 4–6 hearts per group). **P < 0.01 versus control, swimming, 
and iTACginact; Student’s t test with Bonferroni correction. (C) Immunoblotting analysis of SERCA2a, actin, and PI3Kginact protein levels in hearts 
from experimental design II. Densitometric quantification of SERCA2a levels is shown in the bottom panel (n = 6–10 per group). *P < 0.05 versus 
control, †P < 0.05 versus iTAC, ANOVA with Neuman-Keuls correction.
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The integration of neurohumoral and biomechanical stress triggers early bAR 


































































Targeted PI3K inhibition and normaliza-
tion of bAR signaling ameliorates diastolic 
dysfunction in hearts exposed to intermit-
tent pressure overloads. (A–E) Represen-
tative pressure-volume loops obtained by 
gently pulling a suture placed around the 
transverse aorta in control (A), swimming 
(B), iTAC (C), iTACginact (D), and cTAC (E) 
mice after 1 week (experimental design II). 
(F) Change in dP/dtmax in control (n = 11), 
swimming (n = 9), iTAC (n = 9), iTACginact 
(n = 9), and cTAC (n = 15) groups following 
incremental doses (3 minutes each) of dobu-
tamine (1, 2, and 5 mg/ml/min). *P < 0.05 ver-
sus control; Student’s t test with Bonferroni 
correction; †P < 0.05 versus iTAC.
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Beta blocker treatment preserves bAR levels and coupling in response to intermittent pressure overload. (A) Experimental design III. (B) bAR 
density from the cardiac membrane of hearts from the different groups: intermittent sham-operated (iSHAM) mice, in which the iTAC suture was 
placed but never pulled (n = 6), as well as iTAC (n = 6), iTACmeto (n = 6), and iTACginact mice (n = 6). (C) Adenylyl cyclase activity at basal levels 
(white bars) and upon ISO stimulation (black bars). ‡P < 0.01 versus respective basal group; **P < 0.01 versus intermittent sham-operated ISO; 
ANOVA with Bonferroni correction. (D) Intracellular concentration of cAMP in cardiac total cell lysates. **P < 0.01 versus all groups; ANOVA with 
Bonferroni correction. (E) Representative TUNEL staining of cardiac sections. Arrows indicate apoptotic cell nuclei. (F) Summary data of multiple 
independent experiments. **P < 0.01 versus intermittent sham-operated mice.
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desensitization  (24),  recent evidence suggests  that GRKs and 
b-arrestins also perform independent signal transducing functions 
Figure 9
Effects of metoprolol treatment on vascular den-
sity, fibrosis, and in vivo indices of systolic and 
diastolic function. (A) Representative images of 
cardiac sections stained for endothelial alkaline 
phosphatase (magnification, ×400) and summary 
data of different independent experiments. (B) 
Representative immunoblots of cardiac lysates 
for angiopoietin 2 (Ang2) and relative densito-
metric and statistical analysis of multiple indepen-
dent experiments. *P < 0.05, ##P < 0.01 versus 
intermittent sham-operated mice. (C) Bar graphs 
showing percent area of fibrosis in the different 
groups. ##P < 0.01 versus all other groups. (D–F) 
Summary data for t Glantz (D), Ees (E), and the 
slope of the EDPVR (F). *P < 0.05 versus control; 
Student’s t test with Bonferroni correction.
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Exercise models of physiological hypertrophy. Physiological hypertrophy was 
induced in mice as previously described by swimming (15) for 90 minutes 
twice a day or by voluntary running in wheel-equipped cages (16).











The combination of neurohumoral and biomechanical stress is required to trigger early bAR dysfunction in stressed hearts. Plasma levels of 
catecholamines epinephrine (A) and norepinephrine (B) as well as in vitro membrane generation of cAMP (C) and bAR density (D) in cardiac 
membranes prepared from hearts excised immediately after termination of the training protocol or after 12 hours of rest, in the presence or 
absence of metoprolol before treatment. **P < 0.01 versus any stress (A and B) or versus swimming ISO and iTACginact ISO (C).
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Determination of total intracellular cAMP levels. Total cAMP levels were mea-
sured using the AMP-[H3] biotrak assay (TRK432; Amersham Biosciences) 
according to the manufacturer’s instructions.
































Mitogen-activated protein kinase activity. Mitogen-activated protein kinase 
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